Clinical Trials on Transformed Follicular Lymphoma
Total 9681 results
-
Stichting Hemato-Oncologie voor Volwassenen NederlandNordic CLL Study GroupActive, not recruitingChronic Lymphocytic Leukemia in Relapse | Chronic Lymphocytic Leukemia in RemissionNetherlands, Belgium, Denmark, Finland, Norway, Sweden
-
Shanghai Zhangjiang Biotechnology Limited CompanySuspendedB-cell Chronic Lymphocytic LeukemiaChina
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedHematopoietic and Lymphoid Cell Neoplasm | Malignant Solid Neoplasm | COVID-19 InfectionUnited States
-
SpirogenTerminatedAcute Myeloid Leukemia | Chronic Lymphocytic LeukemiaUnited States
-
Mundipharma Research LimitedTerminatedB-cell Chronic Lymphocytic LeukemiaSpain
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)RecruitingHematopoietic and Lymphoid Cell Neoplasm | Malignant Solid Neoplasm | Sarcoma | Lymphoma | Leukemia | Anatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Clinical Stage III Cutaneous Melanoma AJCC v8 | Thyroid Gland Carcinoma | Clinical... and other conditionsUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)RecruitingAcute Lymphoblastic Leukemia | Acute Leukemia | Blastic Plasmacytoid Dendritic Cell Neoplasm | Acute Leukemia of Ambiguous Lineage | Acute Undifferentiated Leukemia | Acute Biphenotypic Leukemia | Myelodysplastic Syndrome With Excess Blasts-1 | Mixed Phenotype Acute Leukemia | Blasts Under 5 Percent... and other conditionsUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Adult Acute Myeloid Leukemia | Adult Acute Promyelocytic Leukemia (M3) | Childhood Myelodysplastic Syndromes | Previously Treated Myelodysplastic Syndromes | Recurrent Adult Acute Lymphoblastic Leukemia | Recurrent Childhood Acute Lymphoblastic Leukemia | Recurrent Childhood Acute Myeloid... and other conditionsUnited States
-
Università Politecnica delle MarcheNot yet recruitingLymphoma | Lung Neoplasms | Tuberculosis | EGF-R Positive Non-Small Cell Lung Cancer | Sarcoidosis | Mediastinal Lymphadenopathy | Hilar Lymphadenopathy | ROS1 Gene Mutation | PDL1 Gene Mutation | ALK TranslocationItaly
-
AmgenTerminatedAcute Myeloid Leukemia | Multiple Myeloma | AML | Myelodysplastic Syndrome | MDS | Non-Hodgkins Lymphoma | NHLUnited States, Australia, Italy, France, Greece, Japan
-
University of South FloridaNational Cancer Institute (NCI); Children's Oncology GroupCompletedSarcoma | Lymphoma | Kidney Cancer | Leukemia | Neurotoxicity | Peripheral NeuropathyUnited States
-
National Cancer Institute (NCI)CompletedEvaluation, Treatment, and Natural History of Children and Young Adults With Cancer or Rare DiseasesLymphoma | Leukemia | Brain Tumors | Rhabdomyosarcoma | Ewing's SarcomaUnited States
-
CelgeneCompletedLymphoma | Acute Myeloid Leukemia | Myelodysplastic Syndromes | Multiple Myeloma | Leukemia, Myelomonocytic, ChronicUnited States
-
Ohio State University Comprehensive Cancer CenterCompletedLymphoma | Small Intestine Cancer | Multiple Myeloma and Plasma Cell NeoplasmUnited States
-
University of California, San FranciscoNational Cancer Institute (NCI)CompletedLymphoma | Myelodysplastic Syndromes | Leukemia | Multiple Myeloma and Plasma Cell NeoplasmUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedLymphoma | Myelodysplastic Syndromes | Leukemia | Multiple Myeloma | Plasma Cell Neoplasm | Myeloproliferative NeoplasmsUnited States
-
University of MinnesotaCompletedSarcoma | Lymphoma | Leukemia | Metabolic Syndrome | Brain and Central Nervous System TumorsUnited States
-
Scripps Translational Science InstituteCue HealthActive, not recruitingImmunoCARE: Rapid, Accurate COVID Testing to Reduce Hospitalization of Immunocompromised IndividualsHIV Infections | Lymphoma | Leukemia | Cancer | Multiple Myeloma | Immunosuppression | Immunodeficiency | Transplant | Graft Versus Host Disease | Age-Related ImmunodeficiencyUnited States
-
Roswell Park Cancer InstituteCompletedLymphoma | Myelodysplastic Syndromes | Leukemia | Multiple Myeloma and Plasma Cell NeoplasmUnited States
-
Jonsson Comprehensive Cancer CenterAmgenCompletedLymphoma | Leukemia | Anemia | Unspecified Adult Solid Tumor, Protocol Specific | Multiple Myeloma and Plasma Cell Neoplasm | Lymphoproliferative Disorder | Precancerous/Nonmalignant ConditionUnited States
-
Swiss Group for Clinical Cancer ResearchCompletedLymphoma | Leukemia | Multiple Myeloma and Plasma Cell Neoplasm | Mature T-cell and Nk-cell NeoplasmsSwitzerland
-
H. Lee Moffitt Cancer Center and Research InstituteReliable Cancer TherapiesTerminatedPain | Lymphoma | Cancer | Neoplasm Metastasis | Multiple Myeloma | Hematologic Malignancy | Tumor | Unresectable Malignant Neoplasm | Malignant Solid TumorUnited States
-
National Institutes of Health Clinical Center (CC)National Cancer Institute (NCI)CompletedLymphoma | Small Intestine Cancer | Lung Cancer | Unspecified Adult Solid Tumor, Protocol Specific | Lymphoproliferative DisorderUnited States
-
Cancer Research UKCompletedLymphoma | Head and Neck Cancer | Gastric Cancer | Nonneoplastic Condition | Lymphoproliferative DisorderUnited Kingdom
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)TerminatedSarcoma | Lymphoma | Breast Cancer | Head and Neck Cancer | Metastatic Cancer | Non-melanomatous Skin CancerUnited States
-
Institut Paoli-CalmettesUnknownLymphoma | Leukemia | Multiple Myeloma and Plasma Cell Neoplasm | Precancerous Condition | Graft Versus Host DiseaseFrance
-
AstraZenecaRecruitingChronic Lymphocytic LeukemiaRomania
-
BeiGeneRecruitingCLLUnited States, Spain, Australia, New Zealand, Korea, Republic of, China, Brazil, Netherlands, United Kingdom, Canada, Poland, Puerto Rico
-
John ReneauRecruitingT-Cell Large Granular Lymphocyte LeukemiaUnited States
-
AstraZenecaRecruiting
-
Hoffmann-La RocheAbbVie; German CLL Study GroupActive, not recruitingLymphocytic Leukemia, ChronicUnited States, Spain, France, United Kingdom, Australia, Canada, Denmark, Germany, Italy, Brazil, Argentina, Estonia, New Zealand, Austria, Bulgaria, Croatia, Romania, Russian Federation, Poland, Switzerland, Mexico
-
Acerta Pharma BVAstraZenecaActive, not recruitingChronic Lymphocytic LeukemiaUnited States, Spain, Canada, Italy, Taiwan, Russian Federation, Turkey, Germany, Korea, Republic of, Brazil, Hungary, Poland, China, Sweden, Bulgaria, Israel, United Kingdom, Australia, Saudi Arabia, Austria, France, Czechia, South... and more
-
AstraZenecaActive, not recruiting
-
Acerta Pharma BVActive, not recruitingChronic Lymphocytic LeukemiaAustria, Italy, Spain, United Kingdom, Belgium, Taiwan, France, Korea, Republic of, Hungary, United States, Ukraine, Canada, Australia, Germany, Israel, Czechia, Russian Federation, Slovakia, Poland, Bulgaria, New Zealand, Sweden, C... and more
-
Janssen Research & Development, LLCPharmacyclics LLC.Active, not recruitingLeukemia, Lymphocytic, Chronic, B-CellCanada, Belgium, Netherlands, Spain, Israel, United States, Czechia, Denmark, United Kingdom, France, Russian Federation, Turkey, Poland, Sweden
-
M.D. Anderson Cancer CenterActive, not recruitingRecurrent T-Cell Prolymphocytic Leukemia | T-Cell Prolymphocytic LeukemiaUnited States
-
TG Therapeutics, Inc.TerminatedChronic Lymphocytic LeukemiaUnited States, Israel, Italy, Poland, Russian Federation, Spain, United Kingdom
-
Acerta Pharma BVActive, not recruitingChronic Lymphocytic LeukemiaUnited States
-
AstraZenecaParexelActive, not recruitingChronic Lymphocytic LeukemiaUnited States, France, Italy, Spain, Sweden, Canada, Denmark, Korea, Republic of, Brazil, Russian Federation, Taiwan, Germany, Australia, Netherlands, Finland, Norway, United Kingdom
-
Georgetown UniversityHackensack Meridian HealthActive, not recruitingChronic Lymphocytic LeukemiaUnited States
-
Northwell HealthCompletedChronic Lymphocytic LeukemiaUnited States
-
German CLL Study GroupAbbVie; Hoffmann-La Roche; Swiss Group for Clinical Cancer Research; Stichting... and other collaboratorsCompletedChronic Lymphocytic LeukemiaIreland, Germany, Israel, Austria, Belgium, Denmark, Switzerland, Finland, Sweden, Netherlands
-
French Innovative Leukemia OrganisationAbbVie; Janssen-Cilag Ltd.Active, not recruitingIntermediate Risk Chronic Lymphocytic Leukemia | Fit Patients | Risk-Adapted and MRD-Driven StrategyFrance
-
Universidade do PortoResearch Centre in Physical Activity, Health and LeisureRecruitingChronic Lymphocytic LeukemiaPortugal
-
AbbVieRecruiting
-
AstraZenecaYgheaRecruitingChronic Lymphocytic LeukemiaItaly
-
Wang XinRecruiting
-
iOMEDICO AGAstraZenecaRecruiting
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI)Recruiting